profit from every $100 of sales.
$0$100
Mannatech
$8.56-4.36% today
-11.5% in 1 year
1-year low $3.951-year high $9.84
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Mannatech sold, what it kept, and what it did with the cash.
Sales went from $137 million in 2022 to $108 million in 2025, with -$15.2 million of profit last year.
SalesProfit
Mannatech vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Mannatech | No profit yet | ||
 Procter & Gamble | 24.4× · Fair price | ||
 L'Oréal | 38.6× · Expensive | ||
 Unilever | 13.5× · Cheap | ||
 Colgate-Palmolive | 36.6× · Expensive |
AI analysis
An AI analyst reads Mannatech's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 137 | 132 | 118 | 108 | |
| 104 | 103 | 91 | 81 | |
| -0 | -1 | 1 | -0 | |
| 1 | 1 | 6 | -1 | |
| -4 | -2 | 2 | -15 | |
| -2.35 | -1.20 | 1.32 | -8.00 | |
| 75.9% | 78.0% | 77.6% | 74.9% | |
| -0.3% | -0.7% | 1.2% | -0.4% | |
| -3.3% | -1.7% | 2.1% | -14.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 49 | 41 | 36 | 30 |
| Cash | 14 | 8 | 11 | 6 |
| Total debt | 6 | 6 | 7 | 7 |
| Total liabilities | 35 | 31 | 27 | 35 |
| 14 | 10 | 9 | -5 | |
| 2 | 2 | 2 | 2 | |
| -1.6% | -4.7% | 20.7% | -92.0% | |
| -31.7% | -21.4% | 28.9% | 291.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -3 | -2 | 2 | -3 | |
| 1 | 1 | 0 | 1 | |
| -4 | -3 | 2 | -4 | |
| Dividends paid | 2 | 1 | 0 | – |
| 2 | 0 | 0 | – | |
| 0 | 0 | 0 | 0 |
Valuation
- –
- –
- –
- -1.9×
- 0.2×
- –
- –
- -26.1%
- -92.1%
- 0.0%
Profitability
- 74.9%
- -0.4%
- -14.1%
- 1.6%
- 1.8%
- -139.1%
- -2,383.3%
- -42.6%
- 2.2%
- –
Growth
- −7.7%
- –
- −319.8%
- −20.4%
- −1.1%
Financial health
- –
- -1.29
- 24.0%
- 1.0×
- 1.09
- 0.59
- 3.56
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 670
Bottom 3%of 674
Bottom 4%of 673
Bottom 1%of 668
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | 0.49 | – | – |
| Apr 15, 2026 | -5.94 | – | – |
| Nov 12, 2025 | 1.01 | – | – |
| Aug 12, 2025 | -2.27 | – | – |
| May 13, 2025 | -0.80 | – | – |
| Mar 26, 2025 | 1.20 | – | – |
| Nov 12, 2024 | -0.17 | – | – |
| Aug 13, 2024 | -0.33 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
18No pass
Benjamin Graham
12No pass
Philip Fisher
42No pass
Peter Lynch
2No pass
Joel Greenblatt
2No pass
Charlie Munger
31No pass
Terry Smith
26No pass
Questions about Mannatech
Is Mannatech a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Mannatech AI analysis
What does Mannatech do?
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. It is in Household & Personal Products.
Does Mannatech pay a dividend?
No. Mannatech does not pay a dividend at the moment.
Is Mannatech stock halal?
No. Mannatech does not pass our halal screen: its debt is 45% of its market value, at or above the 33% limit. How we check
How has Mannatech stock done over the past year?
Down 11.5% over the past twelve months, to $8.56. It traded between $3.95 and $9.84 and is 13.0% below its high.
Who are Mannatech's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Mannatech's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.